Fredrika Killander

722 total citations
25 papers, 411 citations indexed

About

Fredrika Killander is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Fredrika Killander has authored 25 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 16 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Fredrika Killander's work include Breast Cancer Treatment Studies (15 papers), Cancer Cells and Metastasis (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Fredrika Killander is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cancer Cells and Metastasis (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Fredrika Killander collaborates with scholars based in Sweden, United States and United Kingdom. Fredrika Killander's co-authors include Per Malmström, Per Karlsson, Erik Holmberg, Dan Lundstedt, Elisabeth Kjellén, Emma Niméus, Martin Sjöström, Mårten Fernö, Harald Anderson and Anikó Kovács and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Fredrika Killander

22 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fredrika Killander Sweden	12	240	199	94	73	63	25	411
Minyi Cheng China	11	186 0.8×	166 0.8×	79 0.8×	92 1.3×	141 2.2×	37	422
A. Michelotti Italy	11	108 0.5×	210 1.1×	84 0.9×	100 1.4×	25 0.4×	15	372
Cristina Olcese United States	11	316 1.3×	148 0.7×	236 2.5×	50 0.7×	75 1.2×	17	437
Jung Han Yoon South Korea	13	173 0.7×	204 1.0×	104 1.1×	43 0.6×	55 0.9×	40	501
Loes Kooreman Netherlands	15	202 0.8×	135 0.7×	140 1.5×	92 1.3×	158 2.5×	52	558
Wolfram Jaeger Germany	10	111 0.5×	121 0.6×	53 0.6×	29 0.4×	54 0.9×	20	356
Won Kyung Cho South Korea	12	111 0.5×	207 1.0×	72 0.8×	165 2.3×	56 0.9×	56	462
Gabriel Farante Italy	10	506 2.1×	236 1.2×	332 3.5×	44 0.6×	58 0.9×	23	683
Seyran Yiğit Türkiye	14	93 0.4×	181 0.9×	66 0.7×	84 1.2×	62 1.0×	43	433
Meghan Brennan United States	8	211 0.9×	161 0.8×	156 1.7×	70 1.0×	19 0.3×	14	393

Countries citing papers authored by Fredrika Killander

Since Specialization

Citations

This map shows the geographic impact of Fredrika Killander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrika Killander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrika Killander more than expected).

Fields of papers citing papers by Fredrika Killander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrika Killander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrika Killander. The network helps show where Fredrika Killander may publish in the future.

Co-authorship network of co-authors of Fredrika Killander

This figure shows the co-authorship network connecting the top 25 collaborators of Fredrika Killander. A scholar is included among the top collaborators of Fredrika Killander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredrika Killander. Fredrika Killander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marchi, Tommaso De, Niklas Schultz, Lena Tran, et al.. (2025). The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up. BMC Cancer. 25(1). 374–374.

Holmberg, Erik, Fredrika Killander, Emma Niméus, et al.. (2025). Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort. Clinical Cancer Research. 31(7). 1323–1332. 2 indexed citations

Karakatsanis, Andreas, Anne Andersson, Zakaria Einbeigi, et al.. (2024). 339TiP A randomized trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer (ARIADNE). Annals of Oncology. 35. S356–S356. 1 indexed citations

Valachis, Antonios, Henrik Lindman, Daniel R. Smith, et al.. (2024). Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer. JNCI Journal of the National Cancer Institute. 117(6). 1125–1133.

Marchi, Tommaso De, Anna Ehinger, Johan Hartman, et al.. (2023). Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms. Breast Cancer Research. 25(1). 123–123. 14 indexed citations

Marchi, Tommaso De, Gyula Pekár, Lena Tran, et al.. (2023). Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term follow‐up of the SweBCG91RT randomized trial. Molecular Oncology. 17(10). 2029–2040. 3 indexed citations

Sjöström, Martin, Emma Niméus, Fredrika Killander, et al.. (2023). Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial. Clinical Cancer Research. 29(9). 1783–1793. 2 indexed citations

Sjöström, Martin, Erik Holmberg, Per Karlsson, et al.. (2022). Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up. British Journal of Cancer. 126(8). 1145–1156. 34 indexed citations

Puttonen, Henri, Martin Sjöström, Erik Holmberg, et al.. (2020). Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial. Clinical Cancer Research. 27(3). 749–758. 17 indexed citations

10.

Killander, Fredrika, Elinore Wieslander, Per Karlsson, et al.. (2020). No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial. International Journal of Radiation Oncology*Biology*Physics. 107(4). 701–709. 16 indexed citations

11.

Lundstedt, Dan, Fredrika Killander, Erik Holmberg, et al.. (2019). Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes. International Journal of Radiation Oncology*Biology*Physics. 105(2). 285–295. 11 indexed citations

12.

Liljegren, Göran, Fredrika Killander, Henrik Lindman, et al.. (2018). Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. European Journal of Surgical Oncology. 44(7). 951–956. 13 indexed citations

13.

Forsare, Carina, Martin Bak, Dorthe Grabau, et al.. (2018). Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer. BMC Cancer. 18(1). 1226–1226. 2 indexed citations

14.

Killander, Fredrika, Per Karlsson, H. Anderson, et al.. (2016). No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT. European Journal of Cancer. 67. 57–65. 48 indexed citations

15.

Johansson, Ida, Fredrika Killander, Barbro Linderholm, & Ingrid Hedenfalk. (2014). Molecular profiling of male breast cancer – Lost in translation?. The International Journal of Biochemistry & Cell Biology. 53. 526–535. 34 indexed citations

16.

Killander, Fredrika, Harald Anderson, Elisabeth Kjellén, & Per Malmström. (2014). Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy – 25 year follow-up of a randomised trial from the South Sweden Breast Cancer Group. European Journal of Cancer. 50(13). 2201–2210. 22 indexed citations

17.

Höglund, Peter, et al.. (2009). Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). European Journal of Cancer. 45(14). 2488–2495. 60 indexed citations

18.

Killander, Fredrika, Harald Anderson, Stefan Rydén, et al.. (2009). Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer – A randomized trial from the South Sweden Breast Cancer Group. The Breast. 18(5). 309–315. 15 indexed citations

19.

Killander, Fredrika, Harald Anderson, Stefan Rydén, et al.. (2007). Radiotherapy and tamoxifen after mastectomy in postmenopausal women – 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I. European Journal of Cancer. 43(14). 2100–2108. 19 indexed citations

20.

Pero, Ronald W., Håkan Olsson, Fredrika Killander, & Walter Troll. (1992). Elevation of ADP-ribosylation as an indicator of mononuclear leucocyte responsiveness in breast cancer patients treated with tamoxifen. European Journal of Cancer. 28(11). 1803–1806. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact